6-Chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine

Catalog No. :
ACLOES754
CAS No. :
1292577-03-7
Molecular Formula :
C12H12ClN3O2
Molecular Weight :
265.70

IUPAC Name:6-chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine

6-Chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$140.00Login to see priceInquiryInquiry
100mg98%$198.00Login to see priceInquiryInquiry
250mg98%$277.00Login to see priceInquiryInquiry
1g98%$661.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine
IUPAC Name6-chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine
MDL No.MFCD13225368
Molecular FormulaC12H12ClN3O2
Molecular Weight265.70
SMILESCOC1=CC=C(NC2=NC=NC(Cl)=C2)C(OC)=C1
InChI KeyGCRMTOYTRWLDCI-UHFFFAOYSA-N
Synonym6-chloro-N-(2,4-dimethoxyphenyl)pyrimidin-4-amine;4-Pyrimidinamine, 6-chloro-N-(2,4-dimethoxyphenyl)-
CAS No.1292577-03-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLOES754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACONSL354 route compound structure diagram
    ACONSL3542735-04-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLOES754 route product structure diagram
    ACLOES7541292577-03-7
Inquiry

2. ACLOES754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACONSL354 route compound structure diagram
    ACONSL3542735-04-8 In Stock
  2. Plus
  3. ACRQUH457 route compound structure diagram
    ACRQUH45751422-01-6 In Stock
  4. Then
  5. ACLOES754 route product structure diagram
    ACLOES7541292577-03-7
Inquiry

Comments (0)